STAT3 and steatosis: For instance, treatment with IL-6 ameliorated fatty liver by inducing STAT3 phosphorylation in ob/ob and HFD- induced obese mice (Hong et al., 2004), while deletion of IL-6 or hepatic STAT3 resulted in steatosis and hepatocellular damage in IL-10 knockout mice (Miller et al., 2011).